JP2024534118A5 - - Google Patents

Info

Publication number
JP2024534118A5
JP2024534118A5 JP2024511975A JP2024511975A JP2024534118A5 JP 2024534118 A5 JP2024534118 A5 JP 2024534118A5 JP 2024511975 A JP2024511975 A JP 2024511975A JP 2024511975 A JP2024511975 A JP 2024511975A JP 2024534118 A5 JP2024534118 A5 JP 2024534118A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
heavy chain
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024511975A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534118A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/075438 external-priority patent/WO2023028543A2/en
Publication of JP2024534118A publication Critical patent/JP2024534118A/ja
Publication of JP2024534118A5 publication Critical patent/JP2024534118A5/ja
Pending legal-status Critical Current

Links

JP2024511975A 2021-08-25 2022-08-25 抗her2抗体及びその使用方法 Pending JP2024534118A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163237104P 2021-08-25 2021-08-25
US63/237,104 2021-08-25
PCT/US2022/075438 WO2023028543A2 (en) 2021-08-25 2022-08-25 Anti-her2 antibodies and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024534118A JP2024534118A (ja) 2024-09-18
JP2024534118A5 true JP2024534118A5 (https=) 2025-09-01

Family

ID=85322213

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024511975A Pending JP2024534118A (ja) 2021-08-25 2022-08-25 抗her2抗体及びその使用方法

Country Status (12)

Country Link
US (2) US20250136713A1 (https=)
EP (1) EP4392458A4 (https=)
JP (1) JP2024534118A (https=)
KR (1) KR20240052019A (https=)
CN (1) CN117980342A (https=)
AR (1) AR126873A1 (https=)
AU (1) AU2022333088A1 (https=)
CA (1) CA3229542A1 (https=)
IL (1) IL311003A (https=)
MX (1) MX2024002406A (https=)
TW (1) TW202328186A (https=)
WO (1) WO2023028543A2 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7097840B2 (en) * 2000-03-16 2006-08-29 Genentech, Inc. Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
AU2014357292B2 (en) * 2013-11-27 2020-06-25 Zymeworks Bc Inc. Bispecific antigen-binding constructs targeting HER2
SG11201608192SA (en) * 2014-04-11 2016-10-28 Medimmune Llc Bispecific her2 antibodies
EP3609580A4 (en) * 2017-04-09 2021-03-24 Combio Pharmaceutical, Inc. COMMON LIGHT CHAIN BIPARATOPIC AND MULTIPARATOPIC ANTIBODIES AND METHOD OF USE

Similar Documents

Publication Publication Date Title
JP2021533779A5 (https=)
CN102369214B (zh) 三价、双特异性抗体
JP2019502712A5 (https=)
JP2021534096A5 (https=)
CN110914306B (zh) 检查点抑制物双特异性抗体
ES2801873T3 (es) Anticuerpo de PDL-1, composición farmacéutica del mismo y sus usos
JP2019533441A5 (https=)
JP2024150674A5 (https=)
JP2021512630A5 (https=)
IL269395B2 (en) Immunoconjugation of anti-PD-1 antibody with IL-2 or IL-15 mutation
JP2021098732A5 (https=)
JP2018537966A5 (https=)
JP2021510162A5 (https=)
JP2020531438A5 (ja) Nkg2d、cd16、およびhla−eに結合するタンパク質
JP2022551969A5 (https=)
JP2023514371A5 (https=)
JP2021534220A5 (https=)
JP2021522162A5 (https=)
JP2023548045A5 (https=)
JP2019535763A5 (https=)
JP2021510521A5 (https=)
FI3177643T5 (fi) T-soluja aktivoivia bispesifisiä antigeeniä sitovia molekyylejä
JP2020521448A5 (https=)
JP2021533169A5 (https=)
IL292780A (en) A new 4-1bbl trimer containing antigen-binding molecules